Ali A. Habib, MD, discusses how NIMBLE’s hospitalization findings complement symptom outcomes for investigational cemdisiran and highlights pharmacists’ role in vaccination tracking and infection-risk counseling.
|Articles|September 27, 2021
Study: Antibiotic Regimen Can Treat Round Pneumonia in Pediatric Patients
Author(s)Ashley Gallagher, Editor
Treatment of round pneumonia should be followed up with a 2-view chest X-ray weeks later.
Advertisement
Round pneumonia can be treated with antibiotics and should include a follow-up 2-view chest X-ray (CXR) after several weeks to ensure opacity resolution, according to the results of a study published in Radiology Case Reports.
In the case study, investigators monitored a 10-year-old patients with Streptococcus pneumoniae.
The patient was brought to the emergency department with a 5-day intermittent fever of 102º Fahrenheit and a dry cough, as well as malaise and a decreased appetite. Investigators said that the individual had received all recommended vaccinations, provided by the National Vaccine Program.
She had a 98 beats per minute heartrate, her blood pressure was 102/58 mmHg, and her respiratory rate was 34 breaths per minute.
The patient had intact tympanic membranes; a mild injected throat; bilateral small, soft submandibular lymph nodes; and decreased air entry with bronchial breathing. A CXR revealed demarcated homogeneous lesions on the right lobes, which is a sign of round pneumonia.
Laboratory tests revealed normal peripheral blood count, serum electrolyte, serum sugar, serum lactate dehydrogenase, serum uric acid, and renal and liver functions.
A rapid urinary antigen test showed the individual was positive for Streptococcus pneumoniae and blood cultures and a tuberculin test were negative. The patient was treated with intravenous penicillin and gentamicin for 3 days, was discharged, and treated with oral amoxicillin for another 7 days, which is similar to that of lobar pneumonia.
The patient had a follow-up CXR that showed resolving round opacities after 6 weeks. Round pneumonia is mainly present in young patient up to 8 years of age and could be due to underdeveloped collateral airways and inter-alveolar communications, according to the study. This could allow for the dissemination of fluid or bacteria in the lungs.
Reference
AlOmran, HI. Unilateral double round pneumonia in a child: a case report and literature review. Radiol Case Rep.2021;16(11):3266-3269. doi:10.1016/j.radcr.2021.07.066
Advertisement
Related to this article
Pharmacists can address patient fears about fentanyl by distinguishing illicit from prescribed opioids and promoting safe, empathetic, evidence-based opioid use.
Victoria P. Werth, MD, discusses how litifilimab’s 52-week AMETHYST findings inform treatment expectations and timely reassessment of persistent cutaneous lupus symptoms.
In an interview with Pharmacy Times, Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania and chief of dermatology at the Philadelphia VA Medical Center, discusses why meaningful improvement extends beyond skin clearance and how response timing affects patients with difficult-to-control disease.
As psychedelic therapies advance through clinical development, pharmacists should prepare for potential roles in their safe, evidence-based integration into patient care.
In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
The FDA approval of pritelivir offers an oral treatment for refractory HSV lesions in immunocompromised adults, with drug interactions creating an important role for pharmacists.
Weltruza, the first subcutaneous long-acting injectable (LAI) formulation of olanzapine, requires no loading doses, oral supplementation, or postinjection monitoring.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Preparing Pharmacists for Psychedelic Medicine
2
National Pharmacy Technician Day: Celebrating the Backbone of Pharmacy
3
Cemdisiran’s Potential to Reduce Hospitalizations in Myasthenia Gravis
4
Supporting Patients Prescribed Opioids in the Era of “Fentanyl Free America”
5